Home
/ Viatris
/ Competitors

Viatris Competitors and Similar CompaniesClear all

Amgen's competitors and similar companies include Teva Pharmaceuticals and Astellas Pharma.

	Amgen Amgen (formerly known as Applied Molecular Genetics) is a biotechnology company that discovers, develops, manufactures, and delivers human therapeutics.	Teva Pharmaceuticals Teva Pharmaceuticals is a global pharmaceutical company.	Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions.
Founding Date	Founding Date 1980	Founding Date 1901	Founding Date 1923
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare biotech drug development genetics oncology pharma	Tags Healthcare drug development pharma therapy	Tags Healthcare diabetes drug development oncology pharma
Locations	Locations Thousand Oaks, US HQ Hydra, DZ Vicente López, AR Sydney, AU Wien, AT Diegem, BE Santo Amaro, BR see more	Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more	Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more
Employees	Employees 25,200	Employees 37,000	Employees 14,754
Valuation ($)	Valuation ($) 170.4 b	Valuation ($) 20.8 b	Valuation ($) 20.8 b
Financial
Revenue (est.)	Revenue (est.) $36.8b (FY, 2025)	Revenue (est.) $17.3b (FY, 2025)	Revenue (est.) ¥2.1t (FY, 2026)
Cost of goods	Cost of goods $12b (FY, 2025)	Cost of goods $8.3b (FY, 2025)	Cost of goods ¥213.8b (FY, 2026)
Gross profit	Gross profit $24.7b (FY, 2025)	Gross profit $8.9b (FY, 2025)	Gross profit ¥2t (FY, 2026)
Net income	Net income $7.7b (FY, 2025)	Net income $1.4b (FY, 2025)	Net income ¥291.6b (FY, 2026)
Operating ⚠
Facilities	Facilities 180 (FY, 2020)	Facilities 90 (FY, 2019)	Facilities N/A